Annual report
368A.TEDINET S100YIB6
Period2025-04-01 → 2026-03-31
Filed2026-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 134
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥10.9bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥10.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥10.1bn | 2023-04-01 → 2024-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.3bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥5.9bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥5.8bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥5.9bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥5.8bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥6.0bn | 2023-04-01 → 2024-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.1bn | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥5.9bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥5.7bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.9bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.8bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.0bn | 2023-04-01 → 2024-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.4bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥3.9bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥3.8bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥22.0bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥19.7bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥17.9bn | at 2024-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥15.5bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.5bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥20.5bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥18.2bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥16.1bn | at 2024-03-31d | Cons. | Net assets |
| Net assets / equity | ¥14.1bn | at 2023-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥13.4bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥11.5bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥13.4bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.5bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.5bn | at 2024-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.1bn | at 2023-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥3.9bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.5bn | 2023-04-01 → 2024-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.1bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥237m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥880m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥89m | 2023-04-01 → 2024-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥89m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.7bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.1bn | 2023-04-01 → 2024-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.3bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥97.38 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥94.72 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥99.32 | 2023-04-01 → 2024-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥84.26 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥512.61 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥456.24 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥401.51 | at 2024-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥352.19 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 93.2% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.4% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.9% | at 2024-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.9% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 20.1% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 22.1% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 26.4% | 2023-04-01 → 2024-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 25.9% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 83 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 74 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 51 | at 2024-03-31d | Cons. | Number of employees |
| Employees | 44 | at 2023-03-31d | Cons. | Number of employees |
| Revenue | ¥10.7bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥10.1bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥10.0bn | 2023-04-01 → 2024-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥9.3bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥8.1bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥5.7bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥5.6bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥5.8bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥5.6bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥5.9bn | 2023-04-01 → 2024-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.9bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.5bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥5.8bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥5.6bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥3.8bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥3.7bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥3.9bn | 2023-04-01 → 2024-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥3.2bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥3.0bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥21.3bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥19.1bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥17.4bn | at 2024-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥15.1bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥13.4bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.4bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.4bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥19.8bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥17.7bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥15.6bn | at 2024-03-31d | Standalone | Net assets |
| Net assets / equity | ¥13.7bn | at 2023-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥11.7bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥13.2bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥11.1bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥95.28 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥91.69 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥96.73 | 2023-04-01 → 2024-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥80.68 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14,763,498.29 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥41 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥41 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥8,000,000 | 2023-04-01 → 2024-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10,000,000 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥6,000,000 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥495.75 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥441.47 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥389.79 | at 2024-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥343.06 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥58,474,158.82 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 93.2% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.5% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.7% | at 2024-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.1% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.4% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 20.3% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 22.1% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 26.4% | 2023-04-01 → 2024-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 25.4% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 27.5% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 40,000,000 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,000,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 200 | at 2024-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 200 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 200 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 75 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 68 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 49 | at 2024-03-31d | Standalone | Number of employees |
| Employees | 41 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 41 | at 2022-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 1
| Segment | Item | Period | Value |
|---|---|---|---|
| Medical Equipmentreportable segment | employees | at 2026-03-31 | 83 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,117
| Item | Context | Value | Unit |
|---|---|---|---|
| Consolidated statement of comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies for preparation of consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Number of consolidated subsidiaries and names of major consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and reasons for exclusion from scope of consolidation (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and associates and reasons for not being accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Disclosure about fiscal years etc of consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Disclosure of accounting policies (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding shares and bonds etc of unconsolidated subsidiaries and associates (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amount of contract liabilities (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amount of revenue from contracts with customers (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding write downs of inventories (text) | CurrentYearDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYearDuration | Text · Plus | |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding gain on sales of property plant and equipment (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding loss on disposal of property plant and equipment (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYearDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Notes leases consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes financial instruments consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes tax effect accounting consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes revenue recognition consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes segment information etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Description of fact that companys business comprises single segment | CurrentYearDuration | Original text (Japanese)当社グループは、医療機器事業の単一セグメントであるため、記載を省略しております。 | |
| Information for each product or service (text) | Prior1YearDuration | Text · Plus | |
| Revenues from external customers information for each region (text) | Prior1YearDuration | Text · Plus | |
| Property plant and equipment information for each region (text) | Prior1YearDuration | Text · Plus | |
| Information for each of main customers (text) | Prior1YearDuration | Text · Plus | |
| Information for each product or service (text) | CurrentYearDuration | Text · Plus | |
| Revenues from external customers information for each region (text) | CurrentYearDuration | Text · Plus | |
| Property plant and equipment information for each region (text) | CurrentYearDuration | Text · Plus | |
| Information for each of main customers (text) | CurrentYearDuration | Text · Plus | |
| Description of factors which led to recognition of gain on bargain purchase (text) | CurrentYearDuration | Text · Plus | |
| Notes related parties consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes per share information consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes significant events after reporting period consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of corporate bonds (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of borrowings (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of asset retirement obligations (text) | CurrentYearDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYearDuration | Text · Plus | |
| Balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Statement of income (text) | CurrentYearDuration | Text · Plus | |
| Detailed schedule of manufacturing cost (text) | CurrentYearDuration | Text · Plus | |
| Statement of changes in equity (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |